Windtree Therapeutics, Inc. (WINT)

Windtree Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.78	4.32	6.17	22.35	16.93
Cash & Short-Term Investments	1.78	4.32	6.17	22.35	16.93
Cash Growth	-58.81%	-30.02%	-72.38%	32.00%	-25.02%
Prepaid Expenses	0.8	1.06	1.21	1.14	1.19
Total Current Assets	2.57	5.38	7.38	23.49	18.12
Property, Plant & Equipment	1.16	1.63	2.12	3.39	1.84
Goodwill	-	-	3.06	15.68	15.68
Other Intangible Assets	24.13	25.25	25.25	32.07	77.09
Other Long-Term Assets	0.01	0.15	0.15	0.15	0.15
Total Assets	27.88	32.41	37.95	74.79	112.89
Accounts Payable	1.88	0.81	0.25	0.69	1.16
Accrued Expenses	1.71	1.62	1.55	3.41	3.81
Short-Term Debt	0.33	0.23	0.25	0.29	0.35
Current Portion of Leases	0.51	0.44	0.4	0.53	0.81
Other Current Liabilities	1.29	0.9	-	-	-
Total Current Liabilities	5.72	4	2.46	4.92	6.13
Long-Term Debt	-	15	15	15	17.42
Long-Term Leases	0.65	1.16	1.62	2.07	0.2
Long-Term Deferred Tax Liabilities	4.53	5.06	5.06	7.11	16.78
Other Long-Term Liabilities	6.98	3.8	3.8	3.8	2.8
Total Liabilities	17.88	29.02	27.94	32.91	43.33
Common Stock	-	-	-	-	0.02
Additional Paid-In Capital	859.66	851.27	837.6	830.26	790.28
Retained Earnings	-846.61	-844.82	-824.53	-785.32	-717.69
Treasury Stock	-3.05	-3.05	-3.05	-3.05	-3.05
Shareholders' Equity	10	3.39	10.01	41.88	69.55
Total Liabilities & Equity	27.88	32.41	37.95	74.79	112.89
Total Debt	1.49	16.83	17.28	17.89	18.78
Net Cash (Debt)	0.29	-12.51	-11.11	4.46	-1.85
Net Cash Per Share	5.42	-	-	-	-
Filing Date Shares Outstanding	3.56	0.01	-	-	-
Total Common Shares Outstanding	0.26	-	-	-	-
Working Capital	-3.14	1.38	4.92	18.57	11.99
Book Value Per Share	38.99	-	-	-	-
Tangible Book Value	-14.13	-21.86	-18.3	-5.87	-23.22
Tangible Book Value Per Share	-55.13	-	-	-	-
Machinery	1.27	1.26	1.27	5.09	4.98
Leasehold Improvements	2.66	2.66	2.65	2.65	2.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q